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Cryptococcus neoformans is a significant fungal pathogen of immunocompromised patients. Many 
questions remain regarding the function of macrophages in normal clearance of cryptococcal infection 
and the defects present in uncontrolled cryptococcosis. Two current limitations are: 1) The difficulties 
in interpreting studies using isolated macrophages in the context of the progression of infection, and 
2) The use of high resolution imaging in understanding immune cell behavior during animal infection. 
Here we describe a high-content imaging method in a zebrafish model of cryptococcosis that permits 
the detailed analysis of macrophage interactions with C. neoformans during infection. Using this 
approach we demonstrate that, while macrophages are critical for control of C. neoformans, a failure 
of macrophage response is not the limiting defect in fatal infections. We find phagocytosis is restrained 
very early in infection and that increases in cryptococcal number are driven by intracellular proliferation. 
We show that macrophages preferentially phagocytose cryptococci with smaller polysaccharide 
capsules and that capsule size is greatly increased over twenty-four hours of infection, a change that is 
sufficient to severely limit further phagocytosis. Thus, high-content imaging of cryptococcal infection  
in vivo demonstrates how very early interactions between macrophages and cryptococci are critical in 
the outcome of cryptococcosis.
Cryptococcus neoformans is a fungal pathogen of humans that causes life-threatening cryptococcal meningitis in 
immunocompromised patients, in particular those with advanced AIDS1. Cryptococcal meningitis is also found 
associated with a large variety of other immune deficient states, including in patients on immunosuppressive 
therapies2,3, those with hematological malignancy and other more oblique disorders4. However, there are a num-
ber of unifying features in susceptibility to cryptococcal disease, notably a failure in a pro-inflammatory immune 
response to primary infection4–6.
Primary infection with C. neoformans is thought to occur through the lungs where, in the immunocompe-
tent, the first immune cells to encounter cryptococci will most likely be alveolar macrophages. Macrophages 
alone seem unable to clear infection and an adaptive immune response leading to a self-resolving granuloma is 
required7. This is supported by in vitro data demonstrating that C. neoformans appears to be able to efficiently 
parasitise macrophages. Cryptococcus survives and proliferates within the phagosome8, can escape non-lytically9,10 
and may use macrophages as a ‘Trojan horse’11. However, it is not known how host-pathogen interactions at a 
cellular level determine the outcome of cryptococcosis.
Our understanding of cryptococcosis has been based on a combination of clinical studies, in vitro analysis of 
interactions between cryptococci and isolated mammalian cells, and in vivo studies in rodent or leporine hosts. 
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In vitro studies offer the advantage of a highly malleable and observable experimental system, but without direct 
in vivo data on disease progression. In contrast, mammalian models provide the opportunity to study progression 
of infection in vivo, but only permit detailed cellular analysis at specific end points.
Most recently this shortfall has been partly addressed using a zebrafish model of cryptococcal disease12. The 
zebrafish is ideally suited for this approach due to a combination of vertebrate immunity, ease of imaging and 
genetic tractability. Zebrafish have, therefore, been used to model a wide range of human pathogens13–16. Using 
a similar infection model we have developed a high content imaging methodology that permits a full analysis 
of cryptococcal and macrophage cell interactions during infection. Using this approach we demonstrate that 
macrophages are essential for control, but are unable to clear, cryptococcal infection. The ability of macrophages 
to control infection relies on early phagocytosis, which, in turn, is limited by cryptococcal capsule. Finally, we 
show that enlargement of cryptococcal capsule is sufficient alone to overcome macrophage phagocytosis in vivo, 
leading to uncontrolled fungal growth and death.
Results
A method for the live quantification of macrophage behaviour in response to Cryptococcus 
neoformans infection. The quantification of macrophage and cryptococcal interactions in vivo required 
sub-cellular resolution imaging throughout the host, while being able to follow the same infections across an 
extended time period. To achieve this aim we developed repeated high-content live fluorescent imaging, with 
aligned mounting methods, to image 120 individual blood stream infections of 2 days post fertilisation zebrafish 
larvae from 3 biological repeats (each biological repeat was performed as an independent group of 40 infected 
fish; see Supplementary Fig. S1; see Materials and Methods for details of imaging and infection model). Our 
imaging method was sufficiently resolved in x, y and z to identify both macrophage and cryptococcal cells, their 
relative location (Fig. 1a; see Supplementary Fig. S2), and whether cryptococci were intracellular (Fig. 1b,d,f; see 
Supplementary Fig. S2) or extracellular (Fig. 1c,e,g; see Supplementary Fig. S2), throughout the zebrafish. This 
approach allowed us to track individual fungal cells, providing direct counts for the initial fungal burden that were 
indistinguishable from parallel cfu counts (see Supplementary Fig. S1). From these data we directly quantified 
the number of infected macrophages, the number of intracellular cryptococci and total number of cryptococci, at 
2 and 24 hours post infection (hpi). Thus, we were able to calculate the number of extracellular cryptococci, the 
proportion of intracellular cryptococci, the number of cryptococci per macrophage or phagocytic index (PI), and 
changes in total, intracellular, and extracellular cryptococcal cell numbers between 2 and 24 hours of infection 
(see Supplementary Data S1). Importantly, since this quantification was carried out in anaesthetized and fully 
recoverable animals, we were able to place these data in the wider context of subsequent progression of infection 
on an animal-by-animal basis, to investigate the relationship between macrophage responses and disease.
Macrophages are essential for the early control of cryptococcal fungemia. As we were able to 
analyse macrophage responses non-invasively we could also identify time of death in the same experiment. We 
stratified our infections into three groups according to their initial fungal burden and found a dose response in 
survival over 72 hpi but saw little difference before this time point (Fig. 2a). In order to provide finer detail on the 
progression of infection, we used an intermediate dose range (101–102 cryptococci per infection) and measured 
the changes in fungal burden over 72 hpi by fluorescence microscopy (Fig. 2b–f). We observed that there were a 
range of infection outcomes, within this narrow dose range, which we could identify as having low, median and 
high fungal burdens at 72 hpi (Fig. 2b–d, respectively). We quantified this difference by measuring the fungal bur-
den and found that stratification of 72 hpi infection areas at 101–102, 102–104 and > 104 square pixels distinguished 
the same groups (Fig. 2e). Using the 72 hpi divisions we stratified the other time points and found that these 
groups were present at 24 hpi (Fig. 2f). All three groups showed a significant increase in fungal burden relative 
to the initial infection but with very large differences in magnitude. The low, median and high groups showed a 
difference of 2- 10- and 1000-fold increases between 0 and 72 hpi respectively. Having identified differences in the 
progression of infection in our model we wanted to understand how macrophages contributed to such variability 
and we used clodronate-containing liposomes to deplete this cell type specifically17.
Clodronate treatment 24 hours prior to infection (at 24 hpf) resulted in a rapid depletion in macrophage 
numbers, which was stable 72 hours after treatment, with neutrophil numbers unaffected (Fig. 2g). Depletion 
of macrophages using clodronate resulted in a large decrease in survival over 72 hours of infection (Fig. 2h). We 
measured the fungal burden area and, while PBS-containing liposome treatment showed very similar infection 
dynamics to our previous analysis (Fig. 2i), macrophage depletion resulted in uncontrolled infection (Fig. 2j). 
Large differences were already present at 24 hpi and this difference continued to increase at 48 hpi and 72 hpi 
(difference in mean fungal burden 3.9 × 102, 1.3 × 104 and 2.1 × 104 pixels2 respectively; Fig. 2i–k). As depletion 
of macrophages using clodronate prior to infection resulted in uncontrolled infection we next examined the 
influence of macrophage depletion later, when control of infection was observed. To establish controlled infection 
we used a lower initial fungal burden (< 5 × 101) where we observed restricted cryptococcal growth over 72 hpi 
(Fig. 2l) and we depleted macrophages at 24 hpi. We measured the resulting fungal burden and found that fol-
lowing macrophage depletion there was large increase in fungal burden at 48 and 72 hpi (48 hpi 2.3-fold increase, 
P = 0.0026; 72 hpi, 5.6-fold increase, P = 0.0014; Mann-Whitney test; Fig. 2l). Having established the essential 
requirement for macrophages in the control of cryptococcal fungemia early in infection, we returned to the ques-
tion of how the result of the interaction of macrophages with cryptococci influenced the outcome of the infection.
The majority of cryptococci are intracellular after twenty-four hours post infection. We 
hypothesized that the decreased survival observed at high initial fungal burden in wildtype zebrafish (Fig. 2a) 
was due to macrophages being overwhelmed, as we had demonstrated for intermediate and low fungal bur-
den via macrophage depletion (Fig. 2j–l). From this hypothesis we predicted that we would see an increase in 
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macrophage responses (i.e. increases in both the number of macrophages containing cryptococci and the number 
of cryptococci that were intracellular) with increasing inocula up to a threshold where numbers would plateau, 
corresponding to limited macrophage capacity and control of fungal burden. To test this prediction, we deter-
mined the relationship between inoculum and the number of infected macrophages, intracellular cryptococci 
and the phagocytic index, from our macrophage dataset (Fig 3a–f; see Supplementary Data S1). Analysis of all 
three measures identified a significant positive linear relationship to inoculum at 2 hpi (linear regression, all 
P-values < 0.0001; see Fig. 3a–c for individual R2-values) but without plateauing at higher inocula. Interestingly, 
the same relationship was still present at 24 hpi (linear regression, all P-values < 0.0001; see Fig. 3d,e for individual 
Figure 1. Quantification of macrophage behavior in response to Cryptococcus during infection.  
(a) Maximum intensity z-projection of example image data from high content imaging (see Supplementary 
Fig. S1) of Tg(fms:Gal4.VP16)i186 ; Tg(UAS:nfsB.mCherry)i149 zebrafish, with mCherry labeled macrophages 
(magenta), infected with 148 cells of C. neoformans strain H99GFP (green), at 2 hours post infection. (b–d) Areas 
boxed in (a) enlarged and reconstructed in three-dimensions. Arrowheads indicate intracellular cryptococci. 
Image pairs represent different views of same volume with arrows indicating z-axis direction. Image grid is 
20 μ m. Images are representative of a total of 120 infections from n = 3 repeats (40 infections per independent 
repeat group).
www.nature.com/scientificreports/
4Scientific RepoRts | 6:21489 | DOI: 10.1038/srep21489
R2-values). Thus, while essential for control, the capacity of macrophages to respond to increased numbers of 
cryptococci, over the range tested, did not appear to be limiting. This was despite the large differences between 
2 and 24 hpi in absolute numbers of these values. Examining the total number of cryptococci there was only a 
small increase between 2 and 24 hours of infection regardless of the initial fungal burden (median increase 0.89; 
Figure 2. Macrophages are essential for control of cryptococcal fungemia. (a) Stratification of survival 
over 72 hpi from macrophage response data set. Survival is dependent on dose with a large change in 
survival between 101 and 103. 120 infections from n = 3 (each group contains: 100–101 = 23, > 101–102 = 36, 
> 102–103 = 53). (b–f) Representative images and quantitation of fungal burden from infections with inocula 
between > 101–102 of Nacre-strain zebrafish (100 infections from n = 4). (b–d) Fluorescence images of low 
(b), median (c) and high (d). H99GFP infection of zebrafish at 72 hpi with inocula between > 101–102. Scale 
bar is 500 μ m. (e) Quantification of fungal burden using area of fluorescent pixels from C. neoformans strain 
H99GFP. Each point is a separate infection with inocula between > 101–102, with the same 100 infections 
over 72 hours. (f) Stratification of (e) using 2log10 boundaries at 72 hpi. Geometric mean with 95% confidence 
intervals. (g) Zebrafish 24 hpf were injected with clodronate or PBS containing liposomes and the numbers of 
macrophages or neutrophils counted using Tg(mpeg1:mCherryCAAX)sh378 and Tg(mpx:GFP)i114 respectively 
at 6 and 72 hours post treatment. 15 treatments from n = 3. (h) Survival of Nacre-strain zebrafish infected with 
inocula between > 101–102 of C. neoformans strain H99GFP at 48 hpf, following liposome treatment at 24 hpf. 
P < 0.0001, Log-rank (Mantel-Cox). hazard ratio = 4.5 (logrank; 95% confidence interval 3.2,7.7). 140 and 178 
infections from clodronate and PBS groups respectively from n = 3. (i–k) Quantification of fungal burden using 
area of fluorescent pixels from Nacre-strain zebrafish infected with inocula between > 101–102 of C. neoformans 
strain H99GFP at 48 hpf following treatment with liposomes at 24 hpf. Each point the same 75 infections over 
72 hours from n = 3. (i) PBS (j) Clodronate (k) Linear comparison of individual infection and mean fungal 
burden values with PBS (open circles and dotted line respectively) or clodronate (filled circles and solid line 
respectively) treatment. Values are the same as presented (i) and (j). (l) Quantification of fungal burden using 
area of fluorescent pixels from Tg(mpeg1:mCherryCAAX)sh378 strain zebrafish infected with < 5 × 101 of 
C. neoformans strain H99GFP at 48 hpf followed by injection with liposomes at 24 hpi (72 hpf). Points are 
geometric mean with 95% confidence intervals. The same 25 infections over 72 hours.
www.nature.com/scientificreports/
5Scientific RepoRts | 6:21489 | DOI: 10.1038/srep21489
Figure 3. The majority of cryptococci are intracellular at 24 hpi. (a–f) Strong positive correlation between 
inoculum and (a,d) number of infected macrophages, (b,e) number of intracellular cryptococci and, 
(c,f) phagocytic index at (a–c) 2 hpi and (d–f) 24 hpi. (g). Less than an average two-fold increase in the total 
number of cryptococci between 2 and 24 hours. Dotted line represents 1 to 1, whereas dashed line represents 
2 to 1, relationship. Each point is a separate infection. Solid lines are linear regression, all linear regression 
P-values < 0.0001. R-squared values are given for each correlation. (h–k) Shift to majority of cryptococci being 
intracellular after 24 hpi. (h) The proportion of cryptococci intracellular at 2 and 24 hpi for each infection. 
Box plot whiskers are 5 and 95 percentiles with outliers plotted. Medians are 0.22 and 0.58 respectively, 
P < 0.0001 (Mann-Whitney). (i,j) Total, intracellular and extracellular cryptococci numbers at 2 hpi (i) and 
24 hpi (j) for each infection. Box plots with whiskers at 5 and 95 percentiles with outliers plotted. (k) Median 
intracellular and extracellular cryptococci numbers at 2 hpi and 24 hpi calculated from data presented in (I,j). 
For further descriptive statistics and significance comparisons see Table S1. (l–n) Greater increase in number of 
intracellular cryptococci than the number of infected macrophages between 2 and 24 hpi. Dotted line represents 
1 to 1, whereas dashed line represents 2 to 1, relationship. Each point is a separate infection. Solid lines are linear 
regression, all linear regression P-values < 0.0001. R-squared values are given for each correlation. All data are 
of 120 infections of Tg(fms:Gal4.VP16)i186 ; Tg(UAS:nfsB.mCherry)i149 zebrafish with C. neoformans strain 
H99GFP.
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see Supplementary Table S1; Fig. 3g). However, the intracellular and extracellular populations of cryptococci 
changed dramatically between 2 and 24 hpi, with a large shift to the majority of cryptococci being intracellular 
at 24 hpi (Fig. 3h). Analysis of the distribution of the intracellular and extracellular numbers from each infection 
demonstrated that this shift was due to a larger increase in intracellular numbers over static or slightly declining 
extracellular numbers (Fig. 3h–k; see Supplementary Table S1). In addition, there was a much smaller increase in 
the numbers of infected macrophages than in the number of intracellular cryptococci, resulting in an increased 
phagocytic index (Fig. 3l–n). As C. neoformans is able to proliferate within macrophages8 there are two poten-
tial explanations for this observation. Either macrophages that already contain cryptococci are more likely to 
phagocytose further cryptococci (e.g. due to enhanced levels of activation), or this shift is driven by intracellular 
proliferation of cryptococci already within macrophages (with subsequent phagocytosis later in infection having 
only a limited contribution to intracellular burden).
Intracellular proliferation drives increased numbers of cryptococci at twenty-four hours post 
infection. To test our predictions we required high temporal resolution as well as spatial resolution such that 
we could accurately track individual macrophages over time. We used three-dimensional fluorescence time-lapse, 
taking images every 2 minutes over 12 hours, to identify the exploitation of macrophages by cryptococci. The first 
important aspect of macrophage parasitism in vitro that we examined was vomocytosis, the non-lytic expulsion 
of cryptococci from macrophages9,10. The occurrence of vomocytosis has been inferred indirectly in vivo but 
never directly observed18. We found that the mechanics of non-lytic expulsion were conserved in vivo with a 
characteristic exocytic, concave membrane during expulsion19 (arrowhead Fig. 4a; see Supplementary Movie 
S1). In addition, we were able to measure the incidence of vomocytosis and found that 5–15% of macrophages 
expelled cryptococci over 12 hours (Range from n = 9, at least 20 infected macrophages per infection, mean 12%; 
over 12 hours) and this is consistent with values from mammalian studies18,20. Similarly, intracellular prolifera-
tion could be observed clearly, quantified by the timing of each new visible daughter cell, and occurred regularly 
over the 12 hours of observation (Fig. 4b,c). In contrast, phagocytosis was much less frequent, with relatively few 
events in each infection imaged compared to intracellular proliferation (Fig. 4d,e). We therefore concluded that 
the shift in intracellular numbers of cryptococci was due to intracellular proliferation and not phagocytosis, and 
we sought to identify the cryptococcal or macrophage phenotype that was limiting phagocytosis after the first 
hours of infection.
Cryptococci that are phagocytosed within two hours have small polysaccharide capsules that 
are absent from the fungal cell population twenty-four hours post infection. Unlike the numbers 
of infected macrophages and intracellular cryptococci, the proportion of cryptococci that were intracellular at 
2 hpi was only very weakly related to the inoculum (linear regression P = 0.0499, R2 = 0.035; Fig. 5a) i.e. over the 
range of inocula observed, the proportion of cryptococci phagocytosed was stable (median proportion phagocy-
tosed 0.25; 95% CI (0.21, 0.29)). This suggested that there was a consistent subset of the cryptococcal population 
that was not phagocytosed.
In order to understand how modulating phagocytosis influenced the outcome of infection we attempted to 
reduce the phagocytosis of cryptococci by blocking likely uptake pathways. Soluble mannan and glucan have 
been shown to block the uptake of fungal pathogens by macrophages21. However, we found that co-injection of 
these molecules was insufficient to alter uptake of cryptococci by macrophages in our model (see Supplementary 
Fig. S3). The polysaccharide capsule of C. neoformans is its defining clinical microbiological feature and has been 
reported to have a broad range of immunosuppressive activities including preventing phagocytosis22–24. To define 
the role of capsule in the pathogenesis of cryptococcosis in our model we used the cap59 mutant that has severely 
compromised capsule formation25. Infection with the cap59 mutant resulted in zero mortality over 72 hours of 
infection despite using a dose that caused greater than 50% mortality in the parental H99 strain (Fig. 5b). In addi-
tion, analysis of the uptake of the cap59 mutant by macrophages demonstrated that almost all cryptococci were 
intracellular (Median proportion intracellular 0.93; Fig. 5c). Therefore, we hypothesized that differences in cryp-
tococcal capsule size were sufficient to define the limitation of phagocytosis, both in the primary phase following 
infection (Fig. 5a) and later in a secondary phase (> 2 hpi) where phagocytosis was largely curtailed (Fig. 4f).
We predicted that 2 hpi macrophages would contain cryptococci with smaller capsules than extracellular 
cryptococci. To measure the size of the cryptococcal capsule in vivo accurately, we combined immunofluores-
cence labeling of the capsule and staining of the cell wall immediately prior to infection. Live measurement of 
capsule sizes 2 hpi demonstrated that intracellular cryptococci had capsules only about half the radius of extra-
cellular cryptococci capsules (extracellular mean = 0.49 μ m, median = 0.43 μ m; intracellular mean = 0.26 μ m, 
median = 0.24 μ m; P < 0.0001, Mann-Whitney; Fig. 5d–f; see Supplementary Fig. S4). Furthermore, the relative 
frequency of the different intracellular and extracellular capsule sizes was sufficient to closely model the distribu-
tion of phagocytosis values we had quantified from our previous infections (Fig. 5g).
We next investigated the capsule at 24 hpi, the time point after which we had proposed that capsule was lim-
iting phagocytosis. As changes in capsule could not be observed live in the same way as early in infection we 
immuno-labeled fixed tissue and found that by 24 hpi cryptococcal capsule was enlarged, with shed capsular 
material clearly present in surrounding tissue (Fig. 5h). We quantified capsular size ex vivo and found that there 
was a large, and highly consistent, difference in capsule size (Fig. 5i,j; see Supplementary Fig. S4). This large and 
rapid shift in capsule size potentially explained the limitation of phagocytosis later in infection, given the relative 
ability of macrophages to phagocytose cryptococci with different capsule sizes and as there was almost no overlap 
between the capsule size of the initial fungal burden and the fungal cell population at 24 hpi.
Enlargement of capsules of initial fungal burden limits phagocytosis and restricts macrophage 
control of cryptococci. We tested how the modulation of capsule size influenced the outcome of infection 
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by using in vitro culture methods that modified capsule size prior to infection. In vitro culture with NaCl was 
sufficient to significantly reduce capsule size26 (Fig. 6a) but the reduction in capsule was not sufficient to increase 
uptake by macrophages or survival of infection in contrast to the capsule mutant cap59 (Fig. 6b,c). The increase 
in capsule size observed in vivo can be induced in vitro using mammalian serum, increased ambient CO2 con-
centration, limited iron availability increased pH and temperature27–29. We tested combinations of temperature, 
mammalian growth media (MGM), mammalian serum and nutrient starvation for induction of cryptococcal 
capsule similar to those that we had observed in vivo in zebrafish. A combination of MGM, serum and 37 °C 
gave a capsule size much larger than growth in rich media and a distribution very similar to that seen at 24 hpi 
(median = 1.87 μ m vs. 1.81 μ m MGM and 24 hpi respectively, P = 0.24, Mann-Whitney; Fig. 6a).
Using induced capsule cultures we were able to probe the effect on macrophage phagocytosis of enlarged 
capsules at the initiation of infection. When zebrafish were infected with capsule-enlarged C. neoformans there 
were significantly fewer intracellular cryptococci (Fig. 6b,c). Quantification of intracellular cryptococci by live 
fluorescence imaging showed that there was an approximately two-fold reduction in the proportion of intracel-
lular cryptococci (Fig. 6d). This reduction in intracellular cryptococci had a dramatic impact on survival with 
almost 80% mortality and an 8.2 hazard ratio in comparison to non-induced cultures (logrank, 95% confidence 
interval 6.5, 20.0; Fig. 6e) and on fungal burden (difference at 72 hpi 2.8 × 104, P = < 0.0001, Mann-Whitney). We 
Figure 4. Increase in intracellular numbers of cryptococci is driven by proliferation not phagocytosis. 
(a,b,d) Fluorescent time lapse imaging of parasitism of macrophages. Tg(fms:Gal4.VP16)i186; Tg(UAS:nfsB.
mCherry)i149 zebrafish, with mCherry labeled macrophages (c-fms; magenta), infected with C. neoformans 
strain H99GFP (green). Zebrafish were imaged for 12 hours from 2 hpi. Images were captured every 2 minutes. 
(a) Vomocytosis. Selected frames are presented before and after vomocytic event (0 mins). Arrowhead indicates 
the formation of concave macrophage membrane with vomocytosis. Vomocytosed cryptococci leave the 
imaged volume post 48 minutes (see Supplementary Movie S1). Scale bar 10 μ m. (b) Intracellular proliferation. 
Selected frames are presented from when bud is first visible (arrowhead). (c) Quantification of intracellular 
proliferation from time lapse imaging. Each occurrence of intracellular budding yeast was counted over 12 hours. 
Data presented is a cumulative percentage of yeast that budded over the time of observation. (d) Phagocytosis. 
Selected frames are presented from formation of phagocytic cup (arrowhead). (e) Quantification of phagocytosis 
from time lapse imaging. Each occurrence of phagocytosis was counted over 12 hours. Data presented is a 
cumulative percentage of yeast that were phagocytosed over the time of observation. Quantitation of intracellular 
proliferation and phagocytosis are from 22 infected macrophages and are representative of n = 5.
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therefore concluded that increased capsule size at 24 hpi was sufficient to prevent macrophage control of crypto-
coccal infection and led to uncontrolled fungal growth and death.
Discussion
Here we have presented analysis of macrophage and cryptococcal cell interactions that enables analysis at 
a cellular level in vivo, non-invasively and over the course of infection. High quality imaging is the mainstay 
of the zebrafish model and our imaging methodology allows whole organismal imaging of interactions of the 
Figure 5. Polysaccharide capsule is smaller on intracellular cryptococci and is greatly enlarged after 
infection. (a) Association between inoculum and proportion of intracellular cryptococci. Each point is a 
separate infection. P-value 0.0499. 120 infections of Tg(fms:Gal4.VP16)i186 ; Tg(UAS:nfsB.mCherry)i149 
zebrafish with C. neoformans strain H99GFP. (b) Survival of AB strain zebrafish infected with > 102–103 C. 
neoformans strain H99 or mutant cap59. P < 0.0001, logrank (Mantel-Cox). hazard ratio = 10.1 (logrank; 95% 
confidence interval 5.6, 18.4). 89 and 81 infections from H99 and cap59 groups respectively, from n = 8. (c) 
Proportion of intracellular cryptococci 4 hours post infection of Tg(mpeg1:mCherryCAAX)sh378 with > 101–102 
C. neoformans strain H99 or mutant cap59 labelled with Calcofluor white. Quantitation of 22 infected fish from 
n = 3 experiments. (d–f) In vivo measurement of intracellular and extracellular polysaccharide capsule radius. 
1025 cryptococci were measured from 50 infections from n = 5 repeats. (d) Maximum intensity projection from 
three dimensional fluorescence imaging of Tg(mpeg1:mCherryCAAX)sh378 (magenta), that labels macrophage 
membranes, infected with inocula between > 101–102 of C. neoformans strain H99 labeled for polysaccharide 
capsule (green) and cell wall (cyan). Boxed areas are enlarged in i and ii, and are single z-sections. Scale bar is 
20 μ m in left image and 5 μ m in i and ii. (e,f) Intracellular cryptococci have smaller polysaccharide capsules. 
Relative frequency histograms of capsule radius for intracellular (e) and extracellular (f) cryptococci.  
(g) Output of probability model using relative numbers within macrophages from (e,f) to calculate proportion 
of intracellular cryptococci at different inocula given random input (h) Cryptococcal capsule is enlarged and 
shed at 24 hpi. Fixed tissue of AB strain zebrafish infected with > 102–103 C. neoformans strain H99GFP (green) 
at 24 hpi labeled with antibody to capsular polysaccharide (cyan). Scale bar 10 μ m. Boxed areas are enlarged in 
i and ii. Scale bar 5 μ m. (i,j) Cryptococcal capsule size greatly enlarged 24 hpi. Relative frequency histograms 
of capsule radius for inoculum (i) and 24 hpi (j) cryptococci isolated from AB strain zebrafish infected with 
> 102–103 of C. neoformans strain H99. Inset panels are example India ink stained samples. Scale bar 5 μ m. 615 
cryptococci were measured in 12 infections from n = 3.
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Figure 6. In vitro recapitulation of large polysaccharide capsule prevents macrophage phagocytosis  
in vivo. (a) Reduction of cryptococcal capsule in vitro. P < 0.001, Mann-Whitney; Medians YPD = 0.62 μ m, 
YPD 3%NaCl = 0.48 μ m. 632 (YPD) and 345 (YPD 3% NaCl) infections, India ink staining from n = 3.  
(b) Proportion of intracellular cryptococci 2 hpi of Tg(mpeg1:mCherryCAAX)sh378 with > 101–102 C. 
neoformans strain H99GFP grown in YPD or YPD 3% NaCl. Each point represents a separate infection from 
n = 4 plotted with median and standard deviation. (c) Survival of AB-strain zebrafish infected with > 102–103 
of C. neoformans strain H99GFP grown in YPD or YPD 3% NaCl (P = 0.38, logrank (Mantel-Cox)). 55 (YPD) 
and 66 (YPD 3% NaCl) infections, from n = 3. (d) Induction of cryptococcal capsule in vitro. P < 0.001, 
Mann-Whitney, Medians YPD = 0.58 μ m, DMEM 20% FBS = 1.81 μ m. 513 (YPD) and 255 (DMEM 20% 
FBS) India ink staining from n = 3. (e,f) Example maximum intensity projection from three-dimensional 
fluorescence imaging of Tg(fms:Gal4.VP16)i186;Tg(UAS:nfsB.mCherry)i149 (magenta) infected with > 101–102 
of C. neoformans strain H99GFP (green) 2 hpi. Intracellular yeast appear white due co-localisation of both 
colours (e) YPD inoculum. (f) DMEM 20% FBS inoculum. (g) Proportion of intracellular cryptococci 2 hpi of 
Tg(mpeg1:mCherryCAAX)sh378 with > 101–102 C. neoformans strain H99GFP grown in YPD or DMEM 20% 
FBS. Each point represents a separate infection from n = 4 with median and standard deviation. (h) Survival 
of AB-strain zebrafish infected with > 101–102 of C. neoformans strain H99GFP grown in YPD or DMEM 
20% FBS. P < 0.0001, logrank (Mantel-Cox). hazard ratio = 8.2 (logrank; 95% confidence interval 6.5, 20.0). 
57 and 59 infections from YPD and DMEM 20% FBS groups respectively, from n = 3. (i) Linear comparison 
of quantification of fungal burden using area of fluorescent pixels from Nacre-strain zebrafish infected with 
between > 101–102 of C. neoformans strain H99GFP grown in YPD or DMEM 20% FBS. Individual infection 
and mean fungal burden values with H99GFP grown in YPD (open circles and green line respectively) or 
H99GFP grown in DMEM 20% FBS (filled circles and magenta line respectively) treatment. Each point is a 
separate infection; the same 100 (YPD) or 97 (DMEM 20% FBS) infections followed over 72 hours from n = 3. 
Box plots are whiskers at 5 and 95 percentiles with outliers plotted.
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host immune system and pathogen cells, non-invasively throughout a vertebrate host. Single plane illumination 
microscopy (SPIM) and related technologies30,31 offer similar benefits, and have the potential for even higher spa-
tial resolution, but our approach has the advantage of being able to image tens to hundreds of infections, in par-
allel, over a relatively short time period. This means that large datasets can be generated and subjected to robust 
statistical analysis. A major limiting step to be overcome is that image analysis of such datasets remains largely a 
manual task. This is due to the complex nature of the detection and segmentation of immune and pathogen cells, 
and the amount of computation required, as even a single infected zebrafish, at a single time point amounts to 
over a billion voxels.
A potential limitation to the zebrafish model for studying human infection is that the zebrafish are main-
tained at 28 °C as opposed to 37 °C. Nevertheless, zebrafish have been have been used successfully to study a 
wide range of human bacterial and fungal pathogens13–16,32. Host temperature has a clear role in pathogenicity 
of fungal pathogens and is one reason why Cryptococcus neoformans is a significant pathogen of humans when 
other cryptococcal species are not33. However, given that C. neoformans appears able to infect such a wide range 
of animal species, with very different thermoregulation, it is likely that pathogenesis is not dependent of host body 
temperature34. The trehalose pathway of C. neoformans has been shown to be a requirement for growth at 37 °C 
and the trehalose pathway mutant Δ tps1 is avirulent in mice35. However, the Δ tps1 mutant was also avirulent in 
zebrafish at 28 °C and the nematode Caenorhabditis elegans at 25 °C12,35. Similarly, here we have demonstrated that 
changes in cryptococcal capsule during infection of zebrafish agree with mammalian studies and are therefore not 
dependent on body temperature alone.
We sought to understand the behavior of phagocytes during unresolved infection, when the immune system 
must clear growing yeast cells, by injection of cryptococcoci into the circulation. This does not model the likely 
route of human infection of a very low inoculum into the alveolar space but our route of infection directly relates 
to our aim of studying the early events following dissemination of C. neoformans. We note that other models of 
infection are possible with the zebrafish, whereby pathogens are, for example, introduced to single restricted 
tissue sites or, most intriguingly, to the swim bladder, an enclosed air/liquid interface of epithelial/mesothelium 
tissue36–38.
We have demonstrated that, while macrophage phagocytosis of cryptococci contributes to control of infec-
tion, in the absence of adaptive immunity, the developing immune system of zebrafish larvae alone (that can be 
considered a model of vertebrate innate immunity) cannot clear cryptococcal infection. Our model permitted 
unparalleled detail in the progression of cryptococcal infection and we able to observe distinct outcomes of infec-
tion, within narrow ranges of initial fungal burden, that appeared stochastic. The progression of cryptococcal 
infection was very sensitive to differences in dose and, even within small ranges, this may be sufficient to explain 
largely the differences in infection progression. However, there were numerous examples of initial fungal burden 
being independent of severity (see Supplementary Data S1). Therefore a stochastic model (where effect is inde-
pendent of initial fungal burden but the probability of an effect is not) best fits our current understanding of the 
progression of cryptococcal infection and is likely also to be applicable to other aspects e.g. the dissemination to 
the central nervous system.
Nevertheless, macrophages are essential for control, as their depletion had a catastrophic effect on any restric-
tion of fungal burden, even when neutrophil numbers were unaffected. This was also recently demonstrated in 
zebrafish using a transient knockdown of the Spi-1 transcription factor12. In addition, depletion of macrophages 
once infections were controlled still led to increased fungal burden, suggesting they continue to play a critical role 
even after the initial onset of disease. Previous studies that have depleted macrophages in a mouse lung model of 
cryptococcosis have shown differing results. Intratracheal or intranasal administration of clodronate liposomes 
resulted in decreased or unaltered lung fungal burden in three different mouse strains39. However, this approach 
may not deplete macrophages and dendritic cells in surrounding tissues that may be able to compensate for 
local loss40. In contrast, the depletion of CD11c-expressing macrophages and dendritic cells using a diphtheria 
toxin-sensitive transgenic caused no observable difference in lung fungal burden 4 days post infection (dpi) but 
resulted in considerable mortality at 5 dpi40. Our results provide an explanation for this finding, by demonstrating 
that there can be very rapid changes in fungal burden following the loss of macrophage control. Interestingly, 
macrophage depletion late in infection has been demonstrated to be protective in dissemination of C. neoformans 
and provides evidence for the role of the parasitism of macrophages in dissemination during cryptococcosis11.
Our approach also provides validation for multiple aspects of macrophage parasitism by C. neoformans that 
have previously been characterized in vitro. Vomocytosis was originally identified in mammalian macrophages 
and has been demonstrated in environmental amoeboid hosts9,41. However, this study represents the first time 
vomocytosis has been directly observed and quantified in vivo. The impact of vomocytosis during progression of 
cryptococcosis is unknown; does vomocytosis protect host macrophages from parasitism or is it fundamental to 
the dissemination of C. neoformans in cryptococcal meningitis? A previous study was able to infer the occurrence 
of vomocytosis in vivo but required the isolation of macrophages from the lung following infection18. Since this is 
not a limitation for our zebrafish model, there is now the potential to be able to identify when and how vomocy-
tosis contributes to the pathogenesis of cryptococcal infection.
Similarly, intracellular proliferation is a significant in vitro phenomenon but how it contributes to the progres-
sion of infection is not known. In the related pathogen C. gattii, intracellular proliferation closely correlates with 
virulence in mice and humans but this has not been observed for C. neoformans42–44. We have shown that not only 
can intracellular proliferation be directly observed in vivo12 but that intracellular proliferation is the principal fac-
tor driving the shift in the proportion of cryptococci that were intracellular at twenty-four hours post infection. 
Thus, the previously described, apparently, higher proportion of phagocytosis observed at 13 hpi is likely due to 
intracellular proliferation not phagocytosis12. Interestingly, a similar result was observed in C. neoformans infec-
tion of mouse lungs between 2 and 8 hours but using a high fungal inoculum, perhaps explaining the much earlier 
peak in intracellular cryptococci compared to our study45. High intracellular growth will be protective to the host 
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early in infection as there will be limited tissue damage from extracellular growth. Early limitation of damage 
to host tissue by intracellular growth may also contribute to pathogenesis as this will reduce pro-inflammatory 
immune signaling permitting cryptococcal infection to become established.
However, whilst intracellular proliferation proceeds rapidly in vivo, there is little change in extracellular yeast 
numbers early in infection, reflecting the need for extracellular yeast to adapt to the host environment prior to 
the rapid growth seen later in infection. Gene expression analyses during lung infection have demonstrated a 
similar ‘rest’ period for extracellular yeast during adaptation44,46. Intriguingly, this does not appear to be the case 
for intracellular yeast in macrophages, as they are able to proliferate almost immediately. The more rapid changes 
in intracellular yeast gene expression profile may perhaps be part of a host adaptation to dormancy44.
The infectious propagule of human cryptococcosis is most likely a basdiospore or yeast cell desiccated to the 
extent that it is small enough to reach the deep structures of the lung47. In either case the capsule will be very thin 
or absent, unlikely to inhibit phagocytosis, and thus capsule thickness will likely not be a factor for initial infec-
tion in the lungs. Using live imaging of double capsule and cell wall labeled cryptococci in vivo we have shown 
that, even for small capsules following growth in rich media, cryptococcal capsule thickness is a determinant 
of phagocytosis in vivo. The ability of capsular polysaccharide size to interfere with phagocytosis is one of the 
earliest reported findings in cryptococcal pathogenesis22 but the mechanism by which capsule inhibits phago-
cytosis, especially opsonic uptake, remains to be proven48. Where C. neoformans is not controlled and cleared, 
both intracellular and extracellular cryptococci will rapidly develop enlarged capsules45,49. Our data shows that 
polysaccharide capsule enlargement occurs rapidly after infection, with larger capsules seen as early as two hours 
post infection. Cryptococcal capsule enlargement has been described in a zebrafish at 5 dpi12, however, we find 
that similarly enlarged capsules are present by 1 dpi. The enlargement of capsule we see during the first 24 hpi 
infection and infection with C. neoformans with capsules similarly enlarged in vitro, is sufficient to restrict phago-
cytosis severely. Thus, the restriction of phagocytosis for any given dose will increase the number of extracellular 
cryptococci and increase the likelihood of uncontrolled infection. Similar experiments have not been proven to 
be feasible in the mouse lung infection model due to the inability of large encapsulated yeast to enter deep into 
the lung26. Infection with an acapsular mutant of Cryptococcus results in similar fungal burden to a wildtype cryp-
tococcal strain12 and we found that an acapsular mutant was avirulent and almost completely limited to residing 
intracellularly. In vitro restriction of capsule did not significantly alter the outcome of any of these measures, pre-
sumably as the reduction in capsule size was not sufficient to increase phagocytosis and once in the host capsular 
polysaccharide was induced as with the normally cultured strain. We therefore presume that damage to host tis-
sues is associated with extracellular growth as the acapsular is avirulent despite considerable intracellular growth 
and the enhanced mortality in our infections with cryptococci with in vitro induced polysaccharide capsules.
Cryptococci have evolved both to evade phagocytosis and survive within phagocytes50. Here we have demon-
strated a mechanism by which this combination of behaviors, which have presumably evolved to avoid predation 
in the environment50, are particularly destructive in the progression of human cryptococcal infection. The num-
ber of fungal organisms in the initial inoculum of human infection is likely to be very low. Therefore, in healthy 
individuals, with competent adaptive immune responses, it is very likely that all cryptococci will be intracellular 
and will be killed following the pro-inflammatory activation of macrophages. However, in the absence of such 
responses the combination of survival within macrophages and the inhibition of phagocytosis by cryptococcal 
capsule will lead to the uncontrolled progression of infection.
Materials and Methods
Ethics statement. Animal work was carried out according to guidelines and legislation set out in UK law in 
the Animals (Scientific Procedures) Act 1986, under Project License PPL 40/3574. Ethical approval was granted 
by the University of Sheffield Local Ethical Review Panel.
Fish husbandry. We used the Nacre51 and AB strains as our wild type strains, as indicated in the figure leg-
ends. Two macrophage (Tg(fms:Gal4.VP16)i186; Tg(UAS:nfsB.mCherry)i14952 and Tg(mpeg1:mCherryCAAX)
sh378) and one neutrophil (Tg(mpx:GFP)i11453) fluorescent transgenic zebrafish lines were used. Zebrafish 
strains were maintained according to standard protocols54. Adult fish were maintained on a 14:10-hour light/dark 
cycle at 28 °C in UK Home Office approved facilities in the Bateson Centre aquaria at the University of Sheffield.
Transgenic line generation. We generated a transgenic zebrafish with fluorescently labeled macrophage 
membranes using the CAAX motif to cause the prenylation of mCherry. The mpeg1:mCherryCAAX expression 
vector was generated using the Tol2 Kit Gateway system55 by recombining pME-mCherryCAAX with pDestTol-
2pAG2, p3E-PolyA and the mpeg1 promoter entry clone56. The resulting expression vector was used to generate 
Tg(mpeg1:mCherryCAAX)sh378 as described previously54.
C. neoformans culture. The C. neoformans variety grubii strain H99, its GFP-expressing derivative H99GFP 
and the polysaccharide capsule production mutant cap59 were used in this study57. 2 ml YPD (reagents are from 
Sigma-Aldrich, Poole, UK unless otherwise stated) cultures were inoculated from YPD agar plates and grown for 
18 hours at 28 °C, rotating horizontally at 20 rpm. Cells were pelleted at 3300 g, washed twice with PBS (Oxoid, 
Basingstoke, UK) and resuspended in 2 ml PBS. In addition, as the cap59 mutant tended to form cell clumps, the 
washed cap59 cells were incubated at room temperature for thirty minutes and only the top 50 μ l, that contains 
only single or doublet cells, used for infections (other strains used in parallel to the cap59 mutant were treated 
identically). Washed cells were counted with a hemocytometer and used as described below.
C. neoformans capsule induction or restriction. Cultures of H99 GFP were washed and resuspended 
in PBS as described above. For capsule induction 0.5 ml of washed cells for each culture was centrifuged and sus-
pended in 2 ml of Dulbecco’s Modified Eagle’s Medium (DMEM; D5546) with 20% heat inactivated foetal bovine 
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serum (FBS; F9665) to act as the inducing agent. For capsule restriction 0.5 ml of washed cells for each culture was 
centrifuged and suspended in 2 ml of YPD with 3% w/v NaCl to act as the restricting agent. Control cultures were 
also prepared using YPD, and DMEM alone. Cultures were grown for a further 24 hours either rotating at 28 °C 
or in an orbital shaker at 250 rpm at 37 °C. Cultures were then washed three times in PBS to remove residue of the 
different growth media. Induction or restriction of capsule of all cultures was assessed using India ink staining 
described below.
Zebrafish model of C. neoformans infection. The volume of counted, washed cryptococci was calcu-
lated to give the required inoculum in 1 nl, and this volume was pelleted at 3300 g. Pellets were resuspended in 
autoclaved 10% Polyvinylpyrrolidinone (PVP), 0.5% Phenol Red in PBS (PVP is a polymer that increases the 
viscosity of the injection fluid and prevents settling of microbes in the injection needle58). For co-injection of 
mannan and laminarin these were added at 100 μ g/ml. Embryos were anesthetised at 2 days post fertilization 
(dpf) by immersion in 0.168 mg/mL tricaine in E3, transferred onto a microscope slide and covered with 3% 
methyl cellulose in E3 for injection. Two 0.5 nl boluses were injected into the yolk sac circulation valley. Zebrafish 
were transferred to fresh E3 to recover from anaesthetic. Any zebrafish that had visible damage from the injection 
or where the injections were not visually confirmed by the presence of Phenol Red were removed. Zebrafish were 
maintained at 28 °C.
High content imaging method. Infected zebrafish were anesthetized by immersion in 0.168 mg/mL tric-
aine E3 and mounted in agar channels for imaging. Channels were made by adding 200 μ l of 1% agar (Cat. No. 
05039) in E3 containing 0.168 mg/mL tricaine into glass-bottomed, 96-well plates (Porvair sciences, Wrexham, 
UK). Channels were cut in cooled agar using GelX4 tips (Geneflow, Staffordshire, UK). Mounted embryos were 
imaged on a Nikon Ti-E with a CFI Plan Apochromat λ 10X, N.A.0.45 objective lens, a custom built 500 μ m Piezo 
Z-stage (Mad City Labs, Madison, WI, USA) and using Intensilight fluorescent illumination with ET/sputtered 
series fluorescent filters 49002 and 49008 (Chroma, Bellow Falls, VT, USA). Images were captured with Neo 
sCMOS, 2560 × 2160 Format, 16.6 mm x 14.0 mm Sensor Size, 6.5 μ m pixel size camera (Andor, Belfast, UK) and 
NIS-Elements (Nikon, Richmond, UK) using the following settings: 1. GFP, filter 49002, 10 ms exposure, gain 4 
2. mCherry, filter 49008, 10 ms exposure, gain 4. Each zebrafish was imaged as three contiguous fields of view that 
were assigned from bright-field images. 80 z sections, 5 μ m apart, were captured in each channel and each posi-
tion in that order. Each biological repeat contained 40 infected zebrafish, with 3 multi-channel z stacks per fish. 
The microscope was enclosed in a humidified, 28 °C, environmental chamber (Okolabs, Pozzuoli, Italy). After 
imaging larvae were recovered in fresh E3 and returned to a new numbered 96-well plate.
Processing of high content imaging. High content images were not processed for analysis except adjust-
ment of look-up-tables to temporarily increase local contrast. For presentation in Fig. 1a images were projected in 
the z-plane using the maximum intensity pixel method. Three-dimensional reconstructions in Fig. 1 and Fig. S2 
were performed using Imaris (Bitplane, Zurich, Switzerland).
Macrophage response data set. Eight of the 120 infections were censored at 2 hpi and removed from 
the analysis, seven due to having an initial fungal burden of zero and one due to the larvae being damaged by 
the transfer to the imaging plate. A further 2 infections were censored at 24 hpi due to an inability to make the 
counts due to the quality of the imaging files. Any censored or missing values are indicated by ‘NA’ in the data 
tables and were not included in any relevant analysis. The following calculations were performed to obtain values 
for derived counts: number of extracellular cryptococci = total number of Cryptococci − number of intracellular 
cryptococci; proportion of intracellular cryptococci = number of intracellular Cryptococci/total number of cryp-
tococci; phagocytic index = number of intracellular Cryptococci/number of infected macrophages; change in 
cryptococcal numbers between 2 and 24 hpi = (number of cryptococci at 24 hpi-number of cryptococci at 2 hpi)/
number of cryptococci at 2 hpi.
Imaging and colony forming units (CFU) counts. Imaging and CFU counts were compared from the 
same infections. Zebrafish 2 hpi infection were imaged as described above, followed by manual dissociated of 
individual larvae with microcentrifuge pestles in 200 μ l dH20 (this will lyse host cells while leaving fungal cells 
intact42). Dissociates were plated on YPD agar and incubated at 28 °C for 48 hours before counting.
Measurement of fungal burden area. Zebrafish were imaged in 96-well plates using Nikon Ti-E with a 
CFI Plan Achromat UW 2X N.A. 0.06 objective lens, using Intensilight fluorescent illumination with ET/sput-
tered series fluorescent filters 49002 (Chroma, Bellow Falls, VT, USA). Images were captured with Neo sCMOS, 
(Andor, Belfast, UK) and NIS-Elements (Nikon, Richmond, UK). Images were exported as tif files and further 
analysis performed in ImageJ (Schneider et al., 2012). Images were individually cropped to remove the side of the 
96-well or any bright debris or noise within the well. Pixels above the intensity corresponding to C. neoformans 
strain H99GFP were selected using a threshold. The same threshold was used for all images. Thresholded images 
were converted to binary images and the number of pixels counted using the ‘analyse pixel’ function.
Macrophage depletion using clodronate liposomes. Clodronate or PBS liposomes 
(Clodronateliposomes, Amsterdam, The Netherlands) were diluted 1:1 in 10% Polyvinylpyrrolidinone (PVP), 
0.5% Phenol Red in PBS. 1 nl was injected into embryos 1 dpf or 3 dpf (after removal from the chorion) as 
described above. Specific depletion was confirmed using macrophage (Tg(mpeg1:mCherryCAAX)sh378) and neu-
trophil (Tg(mpx:GFP)i114) transgenic zebrafish.
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Time lapse imaging. Time lapse imaging was performed as described for high content imaging with the 
following adjustments: Zebrafish larvae were mounted in 0.8% low melting point agarose (Cat No. A9414) in E3 
containing 0.168 mg/mL tricaine. Images were captured with CFI Plan Apochromat λ 20X, N.A.0.75 objective 
lens, 10 z-sections 2.5 μ m apart, with Perfect Focus system, every 2 minutes for 12 hours.
Survival. Survival was assessed by presence or absence of heart-beat. Statistical analysis was performed as 
described in the text and figure legends.
Live measurement of C. neoformans capsule size. C. neoformans at 1 × 107/ml were labeled with mon-
oclonal antibody 18B7 (a gift from Arturo Casadevall) as described previously19,59. 18B7 labeled cryptococci were 
then labeled with 2.5 μ g/ml FITC secondary antibody and 15 μ g/ml fungal cell wall stain Calcofluor white (Cat 
No. 18909) for 45 mins at 28 °C, rotating horizontally at 20 rpm (the cap59 mutant and H99GFP were similarly 
labeled with Calcofluor white for imaging of cryptococcal uptake in Fig. 5c). Labeled cryptococci were re-counted 
and injections were performed as above. Imaging was performed as for time lapse except at a single time point 
2 hpi and using, in addition, a 31000v2 fluorescent filter for Calcoflour white staining (Chroma, Bellow Falls, VT, 
USA). NIS Elements (Nikon, Richmond, UK) was used to measure capsule radius by subtracting cell wall diam-
eter from capsule diameter and halving.
Antibody staining. Zebrafish larvae were fixed at room temperature in 4% formaldehyde for 30 minutes 
rocking, washed three times in PBS with 0.1% Triton-X and incubated rocking for 10 mins. Washing was repeated 
twice more. Fixed larvae were incubated in 5 μg/ml 18B7 primary antibody in 500 μ l 0.1% Triton-X solution 
rocking at 4 °C for 16 hours. Following primary antibody staining, larvae were washed as above. They were then 
incubated with 5 μg/ml CF350 secondary antibody (Cat No. SAB4600222) in 500 μ l 0.1% Triton-X rocking at 
room temperature for 2 hours, washed as above and mounted on microscope slides with 7 μ l Mowiol solution19 
under 13 mm coverslips.
Probability model for prediction of proportion of intracellular cryptococci. We wrote a Microsoft 
Excel (2011 v14.5.3) spreadsheet containing a probability model that calculated whether an individual crypto-
cocci was phagocytosed or not based on its capsule size. The relative proportions of capsule sizes presented in 
Fig. 5c,d were used to calculate the probability of phagocytosis given such a capsule size. Thus, using a random 
number input, probability of phagocytosis (β ) was calculated from β = IF(A < 0.12,0.71,IF(A < 0.45,0.55,IF(A < 
0.786,0.22,IF(A < 0.94,0.11,0.13)))) where A is a random number between 0 and 1. Successful phagocytosis (φ ; 
i.e. cryptococcal cell was intracellular) was then scored by: φ = IF(A < β ,1,0). φ was calculated for each crypto-
coccal cell in an infection and summed to give the proportion of cryptococci intracellular. The model was run 
repeatedly over the range of initial fungal burdens observed observed and plotted (Fig. 5e) as measured data 
(Fig. 5a).
India ink assay for cryptococcal capsule size. For staining of C. neoformans cultures, equal volumes 
(2 μ l) of cell suspension and India ink (Winsor and Newton, London, UK) were mixed on a microscope slide and 
mounted under a 13 mm coverslip. For staining of cryptococci following infection, zebrafish larvae were dissoci-
ated with microcentrifuge tube pestles in 20 μ l PBS, pelleted at 16300 g for 5 mins, resuspended in 3 μ l PBS, 3 μ l 
of India ink added and mounted as above. India ink samples were imaged on Leica HC upright microscope with 
phase contrast PL APO 100 × 1.4NA objective lens and images captured with ProgRes C14 camera and software. 
ImageJ was used to measure capsule radius by subtracting cell body diameter from total diameter.
Statistical analysis. Statistical analysis was performed as described in the results and figure legends. We 
used Graph Pad Prism 6 (v6.0b) for statistical tests and plots.
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